From: An inventory of collaborative medication reviews for older adults - evolution of practices
Identification criteria | n | % of practices having criteria (n = 12) | % of all practices (n = 43) |
---|---|---|---|
Polypharmacy | 6 | 50 | 14 |
8 medicines in use | 1 | 8 | 2 |
7 medicines or more | 3 | 25 | 7 |
Not defined in detail | 3 | 25 | 7 |
Fala | 5 | 42 | 12 |
Renal dysfunction | 5 | 42 | 12 |
Low GFRb | 2 | 17 | 5 |
GFR under 60 | 1 | 8 | 2 |
GFR under 50 (60) | 1 | 8 | 2 |
Not defined in detail | 1 | 8 | 2 |
Dizziness | 4 | 33 | 9 |
Age | 4 | 33 | 9 |
> 75 years | 3 | 25 | 7 |
Older person, but age not explicitly defined | 1 | 8 | 2 |
Poor response to treatment | 4 | 33 | 9 |
Poor adherence | 3 | 25 | 7 |
Acute decline in general condition | 3 | 25 | 7 |
Increased need to use health services | 2 | 17 | 5 |
Ortostatism | 1 | 8 | 2 |
Delirium or disturbance of consciousness | 1 | 8 | 2 |
Constipation | 1 | 8 | 2 |
Dry mouth | 1 | 8 | 2 |
Concerns regarding possible adverse drug reactions | 1 | 8 | 2 |
Unclear or long medication list | 1 | 8 | 2 |
Multiple psychotropic medicines in use | 1 | 8 | 2 |
Multiple interactions | 1 | 8 | 2 |
Liver dysfunction | 1 | 8 | 2 |
Living at home | 1 | 8 | 2 |